Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
- 27 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (1), 189-202
- https://doi.org/10.1038/s41388-020-01515-5
Abstract
Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of endogenous double-stranded RNAs. ADAR1 is highly expressed in breast cancer including TNBC. Here, we demonstrate that expression of ADAR1, specifically its p150 isoform, is required for the survival of TNBC cell lines. In TNBC cells, knockdown of ADAR1 attenuates proliferation and tumorigenesis. Moreover, ADAR1 knockdown leads to robust translational repression. ADAR1-dependent TNBC cell lines also exhibit elevated IFN stimulated gene expression. IFNAR1 reduction significantly rescued the proliferative defects of ADAR1 loss. These findings establish ADAR1 as a novel therapeutic target for TNBC tumors.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (TL1TR002344, F32GM131514)
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 60 references indexed in Scilit:
- Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinomaNature Medicine, 2013
- Adenosine Deaminase Acting on RNA 1 (ADAR1) Suppresses the Induction of Interferon by Measles VirusJournal of Virology, 2012
- Molecular Stratification of Triple-Negative Breast CancersThe Oncologist, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- A Non-Tumor Suppressor Role for Basal p19ARF in Maintaining Nucleolar Structure and FunctionMolecular and Cellular Biology, 2008
- Higher-Order Substrate Recognition of eIF2α by the RNA-Dependent Protein Kinase PKRCell, 2005
- Translational control in stress and apoptosisNature Reviews Molecular Cell Biology, 2005
- Defects in Translational Regulation Mediated by the α Subunit of Eukaryotic Initiation Factor 2 Inhibit Antiviral Activity and Facilitate the Malignant Transformation of Human FibroblastsMolecular and Cellular Biology, 2004
- Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase GeneJournal of Biological Chemistry, 2004
- Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNAOnline Journal of Public Health Informatics, 2003